Frontlight ResearchEarly access
Trial site
Kunming
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Ankylosing spondylitis1 trial
- Immune thrombocytopenia (ITP)1 trial
- Melanoma1 trial
- Migraine1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026